Clinical trials recruiting for Lung Cancer Stage III
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Carboplatin | 2 |
| Pemetrexed | 2 |
| Bevacizumab | 1 |
| Certolizumab | 1 |
| Cisplatin | 1 |
| Crizotinib | 1 |
| Dabrafenib+Trametinib | 1 |
| Ensartinib | 1 |
| Gemcitabine | 1 |
| Glecirasib | 1 |
| IBI308 | 1 |
| Larotrectinib | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| New Jersey | 1 |
| New York | 1 |
Top cities
Self-screener
Recruiting trials
- Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With Surgery
- Bovine Reinforcement in Stomach, Colorectal and Lung Operation
- COr Loco-regional Advanced Lung Cancer Treated With Chemo-radiotherapy (COLA)
- Clinical Validation and Benchmarking of Top Performing ctDNA Diagnostics - Stage III NSCLC
- Neoadjuvant IBI308, Bevacizumab, Plus Pemetrexed and Carboplatin Followed by Surgery in Unresectable Stage III NSCLC
- Neoadjuvant Umbrella Trial for Patients With Unresectable Stage III NSCLC Harboring Rare Mutations.
Related conditions
Trials recruiting for Lung Cancer Stage III often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Lung Cancer Stage III trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.